73
Views
2
CrossRef citations to date
0
Altmetric
Original Article

XPG gene polymorphisms and glioma susceptibility: a two-centre case–control study

, , , , , , ORCID Icon & show all
Pages 135-140 | Received 14 Oct 2020, Accepted 27 Dec 2020, Published online: 05 Feb 2021

References

  • Pak-Yin Liu A, Moreira DC, Sun C, et al. Challenges and opportunities for managing pediatric central nervous system tumors in China. Pediatr Investig. 2020;4:211–217.
  • Jones DTW, Kieran MW, Bouffet E, et al. Pediatric low-grade gliomas: next biologically driven steps. Neuro Oncol. 2018;20:160–173.
  • Weller M, Wick W, Aldape K, et al. Glioma. Nat Rev Dis Primers. 2015;1:15017.
  • Cordier D, Gerber M, Brand S. Effects of two types of exercise training on psychological well-being, sleep, quality of life and physical fitness in patients with high-grade glioma (who iii and iv): study protocol for a randomized controlled trial. Cancer Commun (Lond). 2019;39:46.
  • Davis ME. Epidemiology and overview of gliomas. Semin Oncol Nurs. 2018;34:420–429.
  • Broniscer A, Baker SJ, West AN, et al. Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. J Clin Oncol. 2007;25:682–689.
  • Terashima K, Chow K, Jones J, et al. Long-term outcome of centrally located low-grade glioma in children. Cancer. 2013;119:2630–2638.
  • Kinnersley B, Labussiere M, Holroyd A, et al. Genome-wide association study identifies multiple susceptibility loci for glioma. Nat Commun. 2015;6:8559.
  • Melin BS, Barnholtz-Sloan JS, Wrensch MR, et al. Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors. Nat Genet. 2017;49:789–794.
  • Wrensch M, Jenkins RB, Chang JS, et al. Variants in the cdkn2b and rtel1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009;41:905–908.
  • Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41:899–904.
  • Dahlin AM, Wibom C, Andersson U, et al. Genetic variants in the 9p21.3 locus associated with glioma risk in children, adolescents, and young adults: A case-control study. Cancer Epidemiol Biomarkers Prev. 2019;28:1252–1258.
  • Rajaraman P, Hutchinson A, Wichner S, et al. DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol. 2010;12:37–48.
  • Chitale S, Richly H. Timing of DNA lesion recognition: ubiquitin signaling in the NER pathway. Cell Cycle. 2017;16:163–171.
  • Lans H, Hoeijmakers JHJ, Vermeulen W, et al. The DNA damage response to transcription stress. Nat Rev Mol Cell Biol. 2019;20:766–784.
  • Mlak R, Krawczyk P, Homa-Mlak I, et al. Predictive value of single nucleotide polymorphisms of ERCC1, XPA, XPC, XPD and XPG genes, involved in NER mechanism in patients with advanced NSCLC treated with cisplatin and gemcitabine. Pathol Oncol Res. 2019;25:1035–1045.
  • Ibarrola-Villava M, Pena-Chilet M, Fernandez LP, et al. Genetic polymorphisms in DNA repair and oxidative stress pathways associated with malignant melanoma susceptibility. Eur J Cancer. 2011;47:2618–2625.
  • He J, Qiu LX, Wang MY, et al. Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet. 2012;131:1235–1244.
  • Hua RX, Zhuo ZJ, Zhu J, et al. XPG gene polymorphisms contribute to colorectal cancer susceptibility: A two-stage case-control study. J Cancer. 2016;7:1731–1739.
  • Zhuo ZJ, Liu W, Zhang J, et al. Functional polymorphisms at ERCC1/XPF genes confer neuroblastoma risk in Chinese children. EBioMedicine. 2018;30:113–119.
  • Consortium GT. Human genomics. The genotype-tissue expression (GTEX) pilot analysis: multitissue gene regulation in humans. Science. 2015;348:648–660.
  • Zhuo Z, Zhou C, Fang Y, et al. Correlation between the genetic variants of base excision repair (ber) pathway genes and neuroblastoma susceptibility in eastern Chinese children. Cancer Commun (Lond). 2020;40:641–646.
  • Dunand-Sauthier I, Hohl M, Thorel F, et al. The spacer region of xpg mediates recruitment to nucleotide excision repair complexes and determines substrate specificity. J Biol Chem. 2005;280:7030–7037.
  • Tsutakawa SE, Sarker AH, Ng C, et al. Human xpg nuclease structure, assembly, and activities with insights for neurodegeneration and cancer from pathogenic mutations. Proc Natl Acad Sci U S A. 2020;117:14127–14138.
  • Chen YZ, Guo F, Sun HW, et al. Association between xpg polymorphisms and stomach cancer susceptibility in a Chinese population. J Cell Mol Med. 2016;20:903–908.
  • Wang F, Zhang SD, Xu HM, et al. Xpg rs2296147 t>c polymorphism predicted clinical outcome in colorectal cancer. Oncotarget. 2016;7:11724–11732.
  • Zhang Z, Yin J, Xu Q, et al. Association between the xpg gene rs2094258 polymorphism and risk of gastric cancer. J Clin Lab Anal. 2018;32:e22564.
  • Crawford EL, Blomquist T, Mullins DN, et al. Cebpg regulates ERCC5/XPG expression in human bronchial epithelial cells and this regulation is modified by E2F1/YY1 interactions. Carcinogenesis. 2007;28:2552–2559.
  • Huang J, Liu X, Tang LL, et al. Xpg gene polymorphisms and cancer susceptibility: evidence from 47 studies. Oncotarget. 2017;8:37263–37277.
  • Han C, Huang X, Hua R, et al. The association between XPG polymorphisms and cancer susceptibility: evidence from observational studies. Medicine (Baltimore). 2017;96:e7467.
  • Mohrenweiser H. Survey of polymorphic sequence variation in the immediate 5ʹ region of human DNA repair genes. Mutat Res. 2007;616:221–226.
  • Wang H, Liu J, Zhang R, et al. The relationship between DNA repair genes (XPA, XPF, XPG) polymorphism and the risk of preeclampsia in Chinese Han women. Pregnancy Hypertens. 2018;14:145–149.
  • Hussain SK, Mu LN, Cai L, et al. Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China. Cancer Epidemiol Biomarkers Prev. 2009;18:2304–2309.
  • Zhou RM, Niu CX, Wang N, et al. XPG gene polymorphisms and the risk of gastric cardia adenocarcinoma. Genet Test Mol Biomarkers. 2016;20:432–437.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.